CMT-3, a chemically modified tetracycline, inhibits pony metastases and delays the development of paraplegia in a rat model of prostate cancer

Marie G. Selzer, Baoqian Zhu, Norman L. Block, Bal L. Lokeshwar

Research output: Contribution to journalArticlepeer-review

41 Scopus citations
Original languageEnglish (US)
Pages (from-to)678-682
Number of pages5
JournalAnnals of the New York Academy of Sciences
StatePublished - 1999
Externally publishedYes

ASJC Scopus subject areas

  • General Neuroscience
  • General Biochemistry, Genetics and Molecular Biology
  • History and Philosophy of Science

Cite this